Teng CM - Search Results

1

Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway.

Hwang TL, Hung HW, Kao SH, Teng CM, Wu CC, Cheng SJ. Hwang TL, et al. Among authors: teng cm. Mol Pharmacol. 2003 Dec;64(6):1419-27. doi: 10.1124/mol.64.6.1419. Mol Pharmacol. 2003. PMID: 14645672

2

Potentiation of tumor necrosis factor-alpha expression by YC-1 in alveolar macrophages through a cyclic GMP-independent pathway.

Hwang TL, Wu CC, Guh JH, Teng CM. Hwang TL, et al. Among authors: teng cm. Biochem Pharmacol. 2003 Jul 1;66(1):149-56. doi: 10.1016/s0006-2952(03)00202-8. Biochem Pharmacol. 2003. PMID: 12818375

3

YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.

Wu CC, Ko FN, Kuo SC, Lee FY, Teng CM. Wu CC, et al. Among authors: teng cm. Br J Pharmacol. 1995 Oct;116(3):1973-8. doi: 10.1111/j.1476-5381.1995.tb16400.x. Br J Pharmacol. 1995. PMID: 8640334 Free PMC article.

4

Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.

Hwang TL, Wu CC, Teng CM. Hwang TL, et al. Among authors: teng cm. Br J Pharmacol. 1998 Nov;125(6):1158-63. doi: 10.1038/sj.bjp.0702181. Br J Pharmacol. 1998. PMID: 9863642 Free PMC article.

5

YC-1 potentiates nitric oxide-induced relaxation in guinea-pig trachea.

Hwang TL, Wu CC, Teng CM. Hwang TL, et al. Among authors: teng cm. Br J Pharmacol. 1999 Oct;128(3):577-84. doi: 10.1038/sj.bjp.0702830. Br J Pharmacol. 1999. PMID: 10516635 Free PMC article.

6

YC-1 potentiates the antiplatelet effect of hydrogen peroxide via sensitization of soluble guanylate cyclase.

Wu CC, Kuo SC, Lee FY, Teng CM. Wu CC, et al. Among authors: teng cm. Eur J Pharmacol. 1999 Sep 24;381(2-3):185-91. doi: 10.1016/s0014-2999(99)00577-4. Eur J Pharmacol. 1999. PMID: 10554886

7

Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3.

Wu CC, Hwang TL, Liao CH, Kuo SC, Lee FY, Lee CY, Teng CM. Wu CC, et al. Among authors: teng cm. Thromb Haemost. 2002 Jun;87(6):1026-33. Thromb Haemost. 2002. PMID: 12083482

8

The role of PAR4 in thrombin-induced thromboxane production in human platelets.

Wu CC, Hwang TL, Liao CH, Kuo SC, Lee FY, Teng CM. Wu CC, et al. Among authors: teng cm. Thromb Haemost. 2003 Aug;90(2):299-308. doi: 10.1160/TH03-02-0103. Thromb Haemost. 2003. PMID: 12888878

9

Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.

Wu CC, Teng CM. Wu CC, et al. Among authors: teng cm. Eur J Pharmacol. 2006 Sep 28;546(1-3):142-7. doi: 10.1016/j.ejphar.2006.07.004. Epub 2006 Jul 14. Eur J Pharmacol. 2006. PMID: 16890935

10

The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation.

Wu CC, Wu SY, Liao CY, Teng CM, Wu YC, Kuo SC. Wu CC, et al. Among authors: teng cm. Br J Pharmacol. 2010 Oct;161(3):643-58. doi: 10.1111/j.1476-5381.2010.00921.x. Br J Pharmacol. 2010. PMID: 20880402 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters